Rare and Uncommon Gynecological Cancers A Clinical Guide

This book is intended as a reference manual that will provide the busy clinician with up-to-date information on the diagnosis and treatment of uncommon and rare gynecological cancers. While standard textbooks briefly cover these tumors, this is intended as a more comprehensive yet easy-to-use guide. After opening chapters on epidemiology, pathology, and diagnostic imaging, the full range of infrequently encountered gynecological cancers (ovarian, uterine, cervical, vaginal, and vulval) is presented and discussed with the aid of high-quality illustrations. In each case, detailed attention is paid to both differential diagnosis and current treatment options. The book has been written by an international panel of experts and is the first to gather all the uncommon and rare gynecological cancers together within one volume.

Introduction.-Epidemiology and data bases.-Pathology.Ovarian Rare Cancers: Ovarian Mucinous Cancers.-Pseudomyxoma peritonei.-Ovarian Clear Cell Cancers 1: The Western View.-Ovarian Clear Cell Cancers 2 :A view from the East.-Borderline and Low grade serous tumours.-Sex cord and stromal tumours.-Squamous Cell Carcinoma Arising within Dermoid.-Carcinosarcomas of Ovary.-Small Cell Carcinomas of Ovary.-Ovarian Carcinoids and Struma Ovarii. Uterine Rare cancers: Uterine Carcinosarcomas.-Uterine Leiomyosarcomas.-Uterine Mucinous Cancers.-Uterine Clear Cell Cancers. Cervix and Vulval Cancers: Small Cell Cancers of Cervix.-Vulval Melanomas.-Gynaecological Cancers in pregnancy.

Dr. Nicholas Reed is a consultant Clinical Oncologist based at the Beatson Oncology Centre in Glasgow, Scotland. He has been a consultant oncologist for more than 25 years and is involved in the delivery of both chemotherapy and radiation treatment for patients with gynaecological, thyroid and neuroendocrine cancers. He has also been committed to the management of rare gynaecological cancers: he was a facilitator for the Gynaecological Cancer InterGroup Rare Tumour sub-group and is currently active in the UK in establishing database, registry and guidelines for these tumours. Dr. Nadeem Siddiqui is a consultant Gynaecological Oncologist and Surgeon based at the Glasgow Royal Infirmary, Scotland, where he leads the team responsible for the surgical care of patients with gynaecological cancers. He is currently the chairman of the Scottish Gynaecological Cancer Trials Group and Chairman of the Cervix committee of the EOIRTC Gynaecological Cancer Group. Dr. John Green is a Senior Lecturer in Cancer Studies at the University of Liverpool, England. He has been involved in the management of gynaecological cancers for 30 years and has been a principal investigator for numerous trials. He has also had a strong commitment to support translational research studies in gynaecological tumours. He has been actively involved in the UK National Cancer Research Institute Gynaecological Cancer Study Group, the EORTC Gynaecological Cancer Group and the Gynaecological Cancer InterGroup. Professor David Gershenson from the MD Anderson Hospital in Texas is one of North America’s most distinguished Gynaecological Oncologists and has published very extensively on gynaecological cancers. His many publications include expert papers on granulosa and sex cord tumours, germ cell tumours, borderline ovarian tumours and other rarer gynaecological cancers. He is a former editor of Gynaecological Oncology and a very senior and active member of the Gynaecological Oncology Group. Dr Rachel Connor is a consultant Radiologist at the Southern General Hospital Glasgow and Lead Radiologist supporting the Gynaecological Cancer Managed Clinical Network for the West of Scotland. She has been a consultant radiologist for over 20 years and was Lead Clinician for Imaging for South Glasgow. She has been an integral member of the West of Scotland Network for Gynaecological cancers since its inception. She has written Imaging guidelines to support the Network, and has been involved in introducing many new techniques to support and develop imaging in Gynaecological cancers locally where she is recognised as a champion. This has all been achieved whilst supporting a full clinical load of routine imaging